ReposiTrak (NYSE:TRAK) CEO Sells 7,500 Shares

Key Points

  • CEO Randall Fields sold 7,500 shares on December 16 at an average price of $13.30 for $99,750, trimming his stake by 4.11% to 175,000 shares (filed with the SEC).
  • Shares traded at $13.30 (up $0.05) on light volume of 9,040 versus a 54,800 average, with a 12‑month range of $12.75–$23.72 and a market cap of about $243.3 million.
  • ReposiTrak reported quarterly EPS of $0.09 with a 30.52% net margin and 14.37% ROE; the consensus rating is Hold, although Wall Street Zen recently upgraded the stock to Buy.

ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall Fields sold 7,500 shares of the business's stock in a transaction dated Tuesday, December 16th. The shares were sold at an average price of $13.30, for a total value of $99,750.00. Following the completion of the sale, the chief executive officer directly owned 175,000 shares of the company's stock, valued at approximately $2,327,500. This trade represents a 4.11% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

ReposiTrak Price Performance

ReposiTrak stock traded up $0.05 during trading hours on Thursday, reaching $13.30. The company had a trading volume of 9,040 shares, compared to its average volume of 54,800. ReposiTrak Inc. has a 12-month low of $12.75 and a 12-month high of $23.72. The company has a 50-day moving average price of $14.29 and a 200 day moving average price of $16.67. The firm has a market cap of $243.26 million, a price-to-earnings ratio of 36.94 and a beta of 0.39.

ReposiTrak (NYSE:TRAK - Get Free Report) last issued its earnings results on Thursday, November 13th. The company reported $0.09 earnings per share (EPS) for the quarter. ReposiTrak had a net margin of 30.52% and a return on equity of 14.37%. The firm had revenue of $5.97 million for the quarter.

Analyst Ratings Changes




A number of research firms have recently weighed in on TRAK. Weiss Ratings reiterated a "hold (c+)" rating on shares of ReposiTrak in a report on Monday. Wall Street Zen upgraded ReposiTrak from a "hold" rating to a "buy" rating in a report on Saturday, December 13th. One investment analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company has a consensus rating of "Hold".

Check Out Our Latest Research Report on TRAK

Hedge Funds Weigh In On ReposiTrak

A number of institutional investors have recently bought and sold shares of the stock. BNP Paribas Financial Markets grew its holdings in shares of ReposiTrak by 63.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 1,633 shares of the company's stock worth $32,000 after acquiring an additional 634 shares during the period. Ingalls & Snyder LLC lifted its stake in shares of ReposiTrak by 1.3% in the 2nd quarter. Ingalls & Snyder LLC now owns 198,714 shares of the company's stock valued at $3,905,000 after purchasing an additional 2,554 shares during the period. Tower Research Capital LLC TRC boosted its position in shares of ReposiTrak by 397.3% during the second quarter. Tower Research Capital LLC TRC now owns 3,620 shares of the company's stock valued at $71,000 after purchasing an additional 2,892 shares in the last quarter. Ellsworth Advisors LLC grew its stake in ReposiTrak by 10.6% in the first quarter. Ellsworth Advisors LLC now owns 31,289 shares of the company's stock worth $634,000 after purchasing an additional 2,997 shares during the period. Finally, Raymond James Financial Inc. grew its stake in ReposiTrak by 22.5% in the third quarter. Raymond James Financial Inc. now owns 17,359 shares of the company's stock worth $257,000 after purchasing an additional 3,185 shares during the period. 27.35% of the stock is owned by institutional investors.

About ReposiTrak

(Get Free Report)

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

See Also

Insider Buying and Selling by Quarter for ReposiTrak (NYSE:TRAK)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at ReposiTrak?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for ReposiTrak and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles